Bozic Carmen (CIK 0001790029)

Latest company ownership

Shares held
32,669
Last filed at
Feb 28, 2025
Confidence Score
49.4
2025Q4
Confidence Score History
2020Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 26, 2025 Feb 28, 2025 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 17.5 -4,962 -13.19% $2.4M
Feb 24, 2025 Feb 26, 2025 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 17.5 -3,310 -8.08% $1.6M
Feb 14, 2025 Feb 19, 2025 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 20.0 -1,912 -4.46% $886.1K
Feb 10, 2025 Feb 12, 2025 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 17.5 -2,142 -5.43% $1M
Aug 7, 2024 Aug 8, 2024 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 23.8 -2,280 -8.93% $1.1M
Jul 24, 2024 Jul 25, 2024 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 23.8 -2,280 -8.20% $1.1M
Jul 10, 2024 Jul 12, 2024 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 23.8 -2,280 -7.58% $1.1M
Jun 26, 2024 Jun 28, 2024 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 27.5 -2,280 -7.04% $1.1M
Jun 12, 2024 Jun 13, 2024 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 27.5 -2,280 -6.58% $1.1M
May 29, 2024 May 31, 2024 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 27.5 -2,280 -6.17% $1M
Feb 23, 2024 Feb 27, 2024 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 17.5 -3,309 -8.22% $1.4M
Feb 16, 2024 Feb 21, 2024 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 17.5 -6,562 -14.02% $2.8M
Feb 9, 2024 Feb 13, 2024 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 20.0 -2,100 -4.29% $887.8K
Nov 14, 2023 Nov 16, 2023 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 15.0 -5,650 -16.17% $2.2M
Oct 31, 2023 Nov 2, 2023 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 20.0 -5,651 -13.92% $2M
Oct 17, 2023 Oct 19, 2023 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 20.0 -5,651 -12.22% $2.1M
Oct 3, 2023 Oct 5, 2023 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 20.0 -5,651 -10.89% $2M
Sep 19, 2023 Sep 21, 2023 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 23.8 -5,651 -9.82% $2M
Sep 5, 2023 Sep 7, 2023 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 23.8 -5,651 -8.94% $2M
Feb 24, 2023 Feb 28, 2023 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 20.0 -3,308 -4.97% $956.4K
Feb 17, 2023 Feb 22, 2023 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 17.5 -3,750 -5.34% $1.1M
Feb 10, 2023 Feb 14, 2023 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 17.5 -7,699 -9.88% $2.3M
May 31, 2022 Jun 2, 2022 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 32.5 -311 -0.62% $84.4K
Feb 24, 2022 Feb 28, 2022 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 20.0 -1,242 -2.43% $283K
Feb 17, 2022 Feb 22, 2022 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 20.0 -3,439 -6.31% $799.6K
Feb 10, 2022 Feb 14, 2022 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 20.0 -2,437 -4.28% $579.4K
May 28, 2021 Jun 2, 2021 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 32.5 -311 -0.93% $65.3K
Feb 24, 2021 Feb 26, 2021 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 32.5 -311 -0.93% $67.7K
Feb 10, 2021 Feb 12, 2021 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 20.0 -2,367 -6.59% $506.9K
May 29, 2020 Jun 2, 2020 VERTEX PHARMACEUTICALS INC / MA EVP and CMO Sell 22.5 -311 -2.17% $87.9K
Feb 24, 2020 Feb 26, 2020 VERTEX PHARMACEUTICALS INC / MA EVP, GMDA Sell 22.5 -216 -1.49% $51.7K